Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7220261 | 0.74 | — | — | |
| SCHEMBL2486985 | 0.72 | ALDH1A1 (0.33) | KDM4E | |
| SCHEMBL7297202 | 0.70 | ALOX15 (0.38) | KDM4EPKM | |
| SCHEMBL491500 | 0.70 | MEN1 (0.31) | — | |
| SCHEMBL1863589 | 0.67 | — | — | |
| SCHEMBL11877166 | 0.67 | — | — | |
| SCHEMBL13327422 | 0.66 | NAMPT (0.32) | — | |
| SCHEMBL24309070 | 0.65 | KDM4E (0.32) | KDM4EPKM | |
| SCHEMBL7909495 | 0.65 | — | — | |
| SCHEMBL499143 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6906098-B2 | Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2005-06-14 | — | — | US | disclosed |
| US-20040019200-A1 | Cycloalkyl-spiro-1, 2,4,5-tetraoxacyclohexane-spiro-cholic acids and derivatives; antiprotozoa agents, bactericides and antitumor agents | ARMY, UNITED STATES | 2004-01-29 | — | — | US | disclosed |
| WO-2003068736-A2 | MIXED STEROIDAL 1,2,4,5-TETRAOXANE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND (US) | 2003-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019200-A1 | Cycloalkyl-spiro-1, 2,4,5-tetraoxacyclohexane-spiro-cholic acids and derivatives; antiprotozoa agents, bactericides and antitumor agents | PKD1, HCCS, POT1 | KDM4E 1781/4885PKM 2900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.